Shanghai Fudan Haitai Biotechnology Co., Ltd. Recruitment information, what about Shanghai Fudan Haitai Biotechnology Co., Ltd.

The data of nailed enterprise code comes from enterprise credit reporting institutions, including enterprise risk data, company official website, company profile, and more company recruitment information. For details, please refer to company official website. For more company telephone addresses and email addresses, you can inquire about nailed enterprise code.

Company profile:

Shanghai Fudan Haitai Biotechnology Co., Ltd. was established in September 2002-10, with a registered capital of 70 million yuan and legal representative Yang Huanfeng. The company's address is Room 342, Traditional Chinese Medicine Innovation Building, Guo Shoujing Road 199, China (Shanghai) Pilot Free Trade Zone, and the unified social credit code and tax number are 9 1365438+. The industry is medical research and experimental development, and the registration authority is the Market Supervision Bureau of the Pilot Free Trade Zone. Its business scope covers biotechnology research and development, production and sales of biological products (excluding drugs) and pharmaceutical intermediates and related "eight skills" services (except the development and application of human stem cells and gene diagnosis and treatment technologies), sales of hardware machinery, electromechanical products, instruments and meters, chemical reagents (excluding dangerous goods), and import and export of goods and technologies. Projects subject to approval according to law can only be operated after approval by relevant departments. The industrial and commercial registration number of Shanghai Fudan Haitai Biotechnology Co., Ltd. is 31015000705097.

Shareholders:

The contribution ratio of Shanghai Haitai Pharmaceutical Co., Ltd. is 74.29%, and the subscribed capital contribution is 52 million yuan.

Gorgeous Family Limited by Share Ltd, with the capital contribution ratio of 15.7 1% and the subscribed capital contribution of 1 1000000.

The contribution ratio of Shanghai Fudan Asset Management Co., Ltd. is 5.7 1%, and the subscribed capital contribution is 4 million yuan.

Hangzhou Taige Pharmaceutical Technology Co., Ltd. contributed 4.29%, and the subscribed capital contribution was RMB 3 million.

Executives:

Zhou Bin is a director of this company.

Jin Zeqing is a director of our company.

Yang Huanfeng is the chairman and general manager of the company.

Qu is a supervisor in this company.

Xia Yinong is a director of the company.

Jiang Weifang is a director of the company.